Literature DB >> 20156334

Is Phytalgic(R) a goldmine for osteoarthritis patients or is there something fishy about this nutraceutical? A summary of findings and risk-of-bias assessment.

Robin Christensen, Henning Bliddal.   

Abstract

A food supplement containing fish oils, urtica dioica, zinc, and vitamin E (Phytalgic) for osteoarthritis (OA) has now been tested in a placebo-controlled trial for 3 months and according to the authors has a very large clinical effect, considerably larger than that of any other known product. Even experts endorsing nutraceuticals for OA symptoms would probably agree that a nutraceutical with an effect size above 0.5 is rarely seen. Despite our concerns about the fact that trial registration took place after the study was completed and the likelihood that patients would note the taste of fish, a circumstance that would lead to detection bias, we consider these data promising though with a high risk of bias.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156334      PMCID: PMC2875636          DOI: 10.1186/ar2909

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  11 in total

Review 1.  Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials.

Authors:  R Christensen; E M Bartels; A Astrup; H Bliddal
Journal:  Osteoarthritis Cartilage       Date:  2007-11-26       Impact factor: 6.576

2.  The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest.

Authors:  Jean-Yves Reginster
Journal:  Arthritis Rheum       Date:  2007-07

3.  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis.

Authors:  H Bliddal; A Rosetzsky; P Schlichting; M S Weidner; L A Andersen; H H Ibfelt; K Christensen; O N Jensen; J Barslev
Journal:  Osteoarthritis Cartilage       Date:  2000-01       Impact factor: 6.576

Review 4.  The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making.

Authors:  Henning Bliddal; Robin Christensen
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 5.  Glucosamine for pain in osteoarthritis: why do trial results differ?

Authors:  Steven C Vlad; Michael P LaValley; Timothy E McAlindon; David T Felson
Journal:  Arthritis Rheum       Date:  2007-07

Review 6.  Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients?--a meta-analysis of randomized controlled trials.

Authors:  R Christensen; E M Bartels; R D Altman; A Astrup; H Bliddal
Journal:  Osteoarthritis Cartilage       Date:  2008-04-14       Impact factor: 6.576

Review 7.  The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.

Authors:  Eveline Nüesch; Sven Trelle; Stephan Reichenbach; Anne W S Rutjes; Elizabeth Bürgi; Martin Scherer; Douglas G Altman; Peter Jüni
Journal:  BMJ       Date:  2009-09-07

8.  Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials.

Authors:  E M Bartels; H Bliddal; P K Schøndorff; R D Altman; W Zhang; R Christensen
Journal:  Osteoarthritis Cartilage       Date:  2009-10-14       Impact factor: 6.576

Review 9.  OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.

Authors:  W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2007-08-27       Impact factor: 6.576

10.  Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.

Authors:  Alain Jacquet; Pierre-Olivier Girodet; Antoine Pariente; Karelle Forest; Laurent Mallet; Nicholas Moore
Journal:  Arthritis Res Ther       Date:  2009-12-16       Impact factor: 5.156

View more
  5 in total

1.  Application of Ultrasound as Clean Technology for Extraction of Specialized Metabolites From Stinging Nettle (Urtica dioica L.).

Authors:  Jana Šic Žlabur; Sanja Radman; Nevena Opačić; Anamaria Rašić; Mia Dujmović; Mladen Brnčić; Francisco J Barba; Juan Manuel Castagnini; Sandra Voća
Journal:  Front Nutr       Date:  2022-05-20

2.  Lipophilic stinging nettle extracts possess potent anti-inflammatory activity, are not cytotoxic and may be superior to traditional tinctures for treating inflammatory disorders.

Authors:  Tyler A Johnson; Johann Sohn; Wayne D Inman; Leonard F Bjeldanes; Keith Rayburn
Journal:  Phytomedicine       Date:  2012-10-23       Impact factor: 5.340

Review 3.  Urtica spp.: Ordinary Plants with Extraordinary Properties.

Authors:  Dorota Kregiel; Ewelina Pawlikowska; Hubert Antolak
Journal:  Molecules       Date:  2018-07-09       Impact factor: 4.411

4.  An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA.

Authors:  Anna Hielm-Björkman; Johanna Roine; Kari Elo; Anu Lappalainen; Jouni Junnila; Outi Laitinen-Vapaavuori
Journal:  BMC Vet Res       Date:  2012-09-06       Impact factor: 2.741

Review 5.  Evidence of Physiotherapy Interventions for Patients with Chronic Neck Pain: A Systematic Review of Randomised Controlled Trials.

Authors:  Pia Damgaard; Else Marie Bartels; Inge Ris; Robin Christensen; Birgit Juul-Kristensen
Journal:  ISRN Pain       Date:  2013-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.